Active Biotech AB (publ) (LON:0GQU)

Market Cap	7.88M
Revenue (ttm)	n/a
Net Income (ttm)	-2.84M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,822
Average Volume	49,427
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.008 - 0.009
Beta	0.49
RSI	n/a
Earnings Date	Feb 13, 2025

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that has completed phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company was incorporated in 198...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 8
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GQU

Financial Performance

Financial numbers in SEK